30 related articles for article (PubMed ID: 2758409)
1. Mode of action of estra-1,3,5(10)-triene-3,17 beta-diol 3-benzoate 17-[4-(4-bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)acet ate) on human breast carcinoma xenografts in nude mice.
Kubota T; Koh J; Yamada Y; Oka S; Enomoto K; Ishibiki K; Abe O; Masui O; Asano K
Jpn J Cancer Res; 1988 Nov; 79(11):1224-9. PubMed ID: 3147278
[TBL] [Abstract][Full Text] [Related]
2. Contrasting actions of estradiol on the growth of human gastric cancer xenografts in nude mice.
Tokunaga A; Onda M; Kiyama T; Nishi K; Mizutani T; Yoshiyuki T; Shimizu Y; Matsukura N; Tanaka N; Asano G
Jpn J Cancer Res; 1989 Dec; 80(12):1153-5. PubMed ID: 2516842
[TBL] [Abstract][Full Text] [Related]
3. A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells.
Zhang XT; Kang LG; Ding L; Vranic S; Gatalica Z; Wang ZY
Oncogene; 2011 Feb; 30(7):770-80. PubMed ID: 20935677
[TBL] [Abstract][Full Text] [Related]
4. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.
Lin SL; Yan LY; Zhang XT; Yuan J; Li M; Qiao J; Wang ZY; Sun QY
PLoS One; 2010 Feb; 5(2):e9013. PubMed ID: 20126312
[TBL] [Abstract][Full Text] [Related]
5. 17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response.
Chinje EC; Williams KJ; Telfer BA; Wood PJ; van der Kogel AJ; Stratford IJ
Br J Cancer; 2002 Jan; 86(1):136-42. PubMed ID: 11857025
[TBL] [Abstract][Full Text] [Related]
6. Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse.
Gibson DF; Johnson DA; Goldstein D; Langan-Fahey SM; Borden EC; Jordan VC
Breast Cancer Res Treat; 1993; 25(2):141-50. PubMed ID: 8347846
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of antiestrogen action in breast cancer.
Jordan VC
Breast Cancer Res Treat; 1994; 31(1):41-52. PubMed ID: 7981455
[TBL] [Abstract][Full Text] [Related]
8. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.
Berry M; Metzger D; Chambon P
EMBO J; 1990 Sep; 9(9):2811-8. PubMed ID: 2118104
[TBL] [Abstract][Full Text] [Related]
9. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
[TBL] [Abstract][Full Text] [Related]
10. [Cell culture--its application in the study of hormone and endometrial carcinoma and feed-back to clinical medicine].
Kuramoto H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1050-5. PubMed ID: 3150847
[TBL] [Abstract][Full Text] [Related]
11. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
[TBL] [Abstract][Full Text] [Related]
12. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
[TBL] [Abstract][Full Text] [Related]
13. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
14. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice.
Satyaswaroop PG; Zaino RJ; Mortel R
Cancer Res; 1984 Sep; 44(9):4006-10. PubMed ID: 6744316
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
